Search over 3,000 reports

    Kivexa - API Insight, 2017

    Kivexa - API Insight, 2017
    Date: Jan, 2018
    Type: Pharmaceutical Industry Report
    Pages: 30
    Geography: Global
    Delivery Timeline: 48 Hours
    SKU: DIDA0080
    "Kivexa - API Insight, 2018" report by DelveInsight provides product and API manufacturers’ details across US, Europe, China and India for Kivexa . It includes Kivexa overview, mechanism, regulatory milestones, deals & partnerships, clinical trials and other development activities. It further provides Kivexa ’s patents information (US & EU). It also features the historical and forecasted sales of Kivexa till 2020. The report also highlights Kivexa ’s market competition and emerging therapies which are in the same space as Kivexa .

    Methodology
    Data used in the report are sourced primarily from internal databases, primary and secondary research and in-house analysis by DelveInsight’s team of industry experts.
    Information and data from the secondary sources have been obtained from various printable and non-printable sources like search engines, news websites, global regulatory authorities websites, trade journals, white papers, magazines, books, trade associations, industry associations, industry portals and access to available databases.

    Scope of the report
    • A comprehensive product overview including product description, regulatory milestones, safety, pharmacological properties, clinical trials, and product development activities have been elaborated in this report
    • Patent information around Kivexa in United States (US) and Europe (EU) has been highlighted
    • API manufacturers for Kivexa in United States, Europe, China and India
    • The report contains historical and forecasted sales for Kivexa till 2020
    • Enlists the market competition and emerging therapies in the space where Kivexa operates

    Reasons to Buy
    • Establish a comprehensive understanding of the drug, Kivexa
    • Access to Kivexa ’s API manufacturers details to devise API procurement strategy for generic development
    • Plan generic developmental timelines around Kivexa ’s patents for the major markets- US and EU
    • Understand Kivexa ’s current and future growth through its historical and forecasted sales
    • Identify the current in-market competitors for Kivexa
    • Identify the product attributes and use it for target finding, drug repurposing, and precision medicine
    • Identify the emerging players and their products operating in the same space as Kivexa
    1. Report Introduction
    2. Kivexa Overview
    • Product Description
    • Mechanism of Action
    • Dosage and Administration
    • Pharmacodynamic Properties
    • Pharmacokinetic Properties
    • Safety and Efficacy of Kivexa
    • Clinical Trial Description
    • Adverse Reactions
    • Product Development Activities
    3. Product Details
    • United States
    • Europe
    4. Kivexa Global Sales Assessment
    • Historical Global Sales
    • Forecasted Global Sales
    5. Patent Details
    6. Global API Manufacturers Assessment
    • United States
    • Europe
    • China
    • India
    7. Market Competitors
    8. Emerging Therapies
    9. Appendix
    • Methodology
    • Consulting Services
    • About DelveInsight
    • Contact Us
    • Disclaimer
    Note: Certain sections of the table of contents would vary according to the availability of information
    Table 1: Kivexa Description
    Table 2: Kivexa Product Details, United States
    Table 3: Kivexa Product Details, Europe
    Table 4: Kivexa , Historical Global Sales till 2017 (in million USD)
    Table 5: Kivexa , Forecasted Global Sales from 2018-2020 (in million USD)
    Table 6: Patent Details: Kivexa
    Table 7: API Manufacturers Region wise
    Table 8: API Manufacturers for United States
    Table 9: API Manufacturers for Europe
    Table 10: API Manufacturers for China
    Table 11: API Manufacturers for India
    Table 12: Kivexa Market Competitors
    Table 13: Emerging Therapies
    Figure 1: Kivexa
    Figure 2: Kivexa , Historical Global Sales till 2017 (in million USD)
    Figure 3: Kivexa , Forecasted Global Sales from 2018-2020 (in million USD)
    Figure 4: Patent Details: Kivexa
    Figure 5: API Manufacturers Region wise
    Kivexa

    Kivexa Marketed Drugs Overview

    Kivexa Market Assessment

    Kivexa API Manufacturers/ Active Pharmaceutical Ingredients Manufacturers

    Kivexa US DMF

    Kivexa US Drug Master Files

    Kivexa Active Substance Master File/ EUDMF

    Kivexa Generic players

    Kivexa Patent Expiration

    Kivexa Patent Exclusivity

    Kivexa API Manufacturers

    Kivexa Global Forecasted Sales Figure

    • Single User License
      (20% Off)
      $500.00
    • Site License
      (30% Off)
      $1,000.00
    • Global License
      (40% Off)
      $1,500.00

    Contact Us

    Phone
    +91-11-45689769, +91 9650213330

    Email
    info@delveinsight.com

    Address
    New Delhi-110075, India

    Latest Tweets

    • Copyright © 2017 Delveinsight.
    • Sitemap